Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immutep Ltd (AU:IMM)
:IMM
IMM Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.23 - AU$0.48
Previous CloseN/A
Volume844.76K
Average Volume (3M)1.19M
Market Cap
AU$494.90M
Enterprise ValueAU$178.55M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.06
Next Earnings
Aug 27, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding1,455,589,600
10 Day Avg. Volume1,164,492
30 Day Avg. Volume1,185,852
Standard Deviation0.19
R-Squared0.25
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)209.01
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.45Price Target Upside327.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Immutep Ltd News
PremiumCompany Announcements
Immutep Limited Reports Cessation of Securities
PremiumCompany Announcements
Immutep Ltd Updates Stakeholders on Business Progress
PremiumCompany Announcements
Immutep Completes Patient Enrolment for Key Phase II Cancer Trial
PremiumCompany Announcements
Immutep Completes Enrolment for Promising INSIGHT-003 Cancer Trial---
Options Prices
Currently, No data available
---
Ownership Overview
1.14% Insiders
0.02% Mutual Funds
― Other Institutional Investors
98.66% Public Companies and
Individual Investors
IMM FAQ
What was Immutep Ltd’s price range in the past 12 months?
Immutep Ltd lowest share price was AU$0.23 and its highest was AU$0.48 in the past 12 months.
What is Immutep Ltd’s market cap?
Immutep Ltd’s market cap is AU$494.90M.
When is Immutep Ltd’s upcoming earnings report date?
Immutep Ltd’s upcoming earnings report date is Aug 27, 2025 which is in 187 days.
How were Immutep Ltd’s earnings last quarter?
Currently, no data Available
Is Immutep Ltd overvalued?
According to Wall Street analysts Immutep Ltd’s price is currently Undervalued.
Does Immutep Ltd pay dividends?
Immutep Ltd does not currently pay dividends.
What is Immutep Ltd’s EPS estimate?
Immutep Ltd’s EPS estimate is -0.02.
How many shares outstanding does Immutep Ltd have?
Immutep Ltd has 1,455,589,600 shares outstanding.
What happened to Immutep Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Immutep Ltd?
Currently, no hedge funds are holding shares in AU:IMM
---
Immutep Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$1.45 (327.85% Upside)
AU$1.45 (327.85% Upside)
Blogger Sentiment
Bullish
AU:IMM Sentiment 70%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.04%
12-Months-Change
Fundamentals
Return on Equity
-25.75%
Trailing 12-Months
Asset Growth
37.16%
Trailing 12-Months
Company Description
Immutep Ltd
Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
---
IMM Stock 12 Month Forecast
Average Price Target
AU$1.45
▲(327.85% Upside)
Technical Analysis
Acrux Limited
―
Opthea Limited
―
PYC Therapeutics Limited
―
Proteomics International Laboratories Ltd.
―
Best Analysts Covering IMM
1 Year
1 Year Success Rate
5/14 ratings generated profit
1 Year Average Return
-3.10%
reiterated a buy rating 6 months ago
Copying Melissa Benson's trades and holding each position for 1 Year would result in 35.71% of your transactions generating a profit, with an average return of -3.10% per trade.
---